The toxin Candidalysin of the yeast Candida albicans is incorporated into an unusual protein structure during an infection, which has so far been unknown to scientists. By modifying the protein structure, the pathogenicity of the fungus could also be reduced. This opens up a new way of treating persistent forms of vaginal Candida infection.